Non-Alcoholic fatty liver disease (NAFLD) - The hepatic component of metabolic syndrome

Journal of Association of Physicians of India

Volumn 57, Issue 3, 2009, Pages 201-204

  Uchil, Deepa ^b   Pipalia, D ^b   Chawla, M ^b   Patel, R ^b   Maniar, Sonali ^b   Narayani, ^b   Juneja, Archana ^a  

^a Wockhardt Hospitals India   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIPID;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; CASE CONTROL STUDY; COHORT ANALYSIS; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; COHORT STUDIES; FATTY LIVER; FEMALE; HEPATITIS; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 68949092651     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Jeanne M, Clark, Federick L, Brancati and Mae Dhiel, et al. Non Alcoholic Fatty Liver Disease. Gastoenterology 2002; 122.: 1649-1669.
2. Scaffner F, Thaler H, et al. Non Alcoholic Fatty Liver Disease - A progressive liver disease. Scandinavian Journal of Gastroenterology 1986; 8: 283-93.
3. Cortez, Pinto H, Camilu M, Bapista, et al. NAFLD -Another feature of metabolic syndrome. Diabetes 1996; 36: 185-92.
4. Pratt DS, Kaplan MM, et al. Evaluation of abnormal liver enzymes results in asymptomatic patients. New England Journal of Medicine 2000; 342: 1266-1271.
5. Zelber-Sagi, S Nitzan, Kauski D, Halpern, et al. Prevalennce of NAFLD in population based study and its association with anthropometric and biochemical measures. Liver Int 2006; 7: 856-863
6. Joseph A.E, Saverymuttu S H, Al-Sams, Cook M G, et al. Comparison of liver histology with USG in assessing diffuse parenchymal liver disease. Radiology 1991;43:26-31.
7. Debacre C, Rigauts H, Laukens, et al. Transient focal fatty infiltration mimicking liver metastasis. Radiology 1998; 81: 174-185.
8. Mitchell DG, et al. Focal manifestations of diffuse liver disease at M. R. Imaging. Radiology 1992; 185: 1-11
9. Longo R, Polle Sello P, Ricci, et al. Proton MR spectroscopy in quantitative in vivo determination of fat in human liver steatosis. Journal of M.R. Imaging 1995; 5: 281-285.
10. Younossi ZM, Diehl AM, Ong J P, et al. Non Alcoholic Fatty Liver Disease- an agenda for clinical research. Hepatology 2002; 35: 746-742.
11. Brunt EM, Ramrahkiani S, Lordes BG, et al. Concurrence of Histological features of Steatohepatitis with other forms of chronic liver diseases. Modern Pathology 2003; 16: 49-56.
12. Hegen, Ansert SL, et al. Abdominal and retroperitoneal cavities. Diagnostic Ultrasonography. 196:120-126.
13. Expert panel on detection evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of NCEP. Journal of American Medical Association. 2001; 285: 2486-2497.
14. Nomora H, Kashiwagi S, Hayashi, et al. Prevalence of fatty liver in the general population of Okinawa, Japan. Japanese Journal of Medicine 1998; 27: 142-149.
15. Singh SP, Nayak S, Swarn M, et al. Prevalence of NAFLD in eastern coastal India-A Preliminary USG study. Tropical Gastroenterology 2004; 2: 76-79.
16. Marchesini, Brizi M, Bianchi et al. NAFLD - A feature of metabolic syndrome. Diabetes 2001; 50: 1844-1850.
17. Dixon J R, Bathol P S Obrien Pe, et al. NASH-Predictors of liver fibrosis in severely obese. Gastroenterology 2001; 12: 91-100.
18. Goland S, Shimoni S, Zornitzki, Knobler, et al. Cardiac manifestations-A new manifestation of NAFLD. Journal Clinical Gastroenterology 2006; 40: 949-55.
19. Lee S, Jin Kim Y, Yong Jeon T, Hoi Kim H, et al. Obesity -The only independent factor in NAFLD. Scandinavian Journal of Gastroenterology. 2006; 41: 566-71.
20. Eriksson S Eriksson K F, Bondesson L, et al. Non alcoholic steatohepatitis in obesity: A reversible condition. Acta Med Scand 1986; 220:83-88.